Truist on Globus Medical (GMED): 'We Expect GMED Shares to React Positively to Preliminary 4Q Results'
Tweet Send to a Friend
Truist Securities analyst Richard Newitter reiterated a Hold rating and $90.00 price target on Globus Medical (NYSE: GMED).The analyst said ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
